Abstract 3232: Combined inhibition of mTOR and HSP90 potentiates cisplatin antitumor effect and reverts cisplatin resistance <i>in vitro</i> and <i>in vivo</i> models of epithelial ovarian cancer by modulating HSF1-dependent transactivation

Authors: Rita Lombardi, Laura Addi, Biagio Pucci, Maura Sonego, Maria Serena Roca, Francesca Capone, Federica Iannelli, Francesca Bruzzese, Gustavo Baldassarre, Alfredo Budillon

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-3232

Source: Full article